Skip to main content
Equibles

Krensavage Asset Management, LLC

Position in ARDX — Ardelyx, Inc.

CIK 1609251 NEW YORK, NY
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,726,067
-$268,933 QoQ
Shares Held
534,523
+6.9% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#44
of 250 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Krensavage Asset Management, LLC holds $164,705,918 across 9 Biotechnology names. ARDX ranks #9 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ENTA
Enanta Pharmaceuticals Inc
 2,866,138 $41,788,292
2 JAZZ
Jazz Pharmaceuticals plc
 167,816 $40,438,621
3 BMRN
Biomarin Pharmaceutical Inc
 524,786 $30,028,254
4 EXEL
Exelixis, Inc.
 370,693 $20,169,406
5 RARE
Ultragenyx Pharmaceutical Inc.
 390,879 $13,051,449
6 VNDA
Vanda Pharmaceuticals Inc.
 1,180,388 $7,223,974
7 BNTX
BioNTech SE
 59,523 $5,538,615
8 REGN
Regeneron Pharmaceuticals, Inc.
 6,000 $3,741,240

All Filings in ARDX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,726,067 534,523
2026-03-31 $2,995,000 500,000